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Abstract Saliva is a non-invasive source of biomarkers
useful in the study of physiological mechanisms. More-
over, this fluid has diverse functions, among which food
perception and ingestion, making it particularly suitable
for the study of obesity. The aims of this study were to
assess changes in salivary proteome among morbidly
obese women, with a view to provide information about
mechanisms potentially related to the development of
obesity, and to evaluate whether these changes persist
after weight loss. Mixed saliva samples from morbidly
obese women (N=18) who had been either subjected
(group O-BS) or not (group O) to bariatric surgery and
women with normal weight (N=14; group C) were
compared for protein profiles, alpha-amylase abundance
and enzymatic activity, and carbonic anhydrase (CA) VI
abundance. Differences in salivary obese profiles were
observed for 23 different spots. Zinc-alpha-2
glycoprotein-containing spots showed higher abun-
dance in group O only, whereas cystatin S-containing
spots presented higher abundance in the two groups of
obese subjects. Most of the spots identified as salivary
amylase were present at lower levels in group O-BS.
With regard to the amylase enzymatic activity, increases
were observed for group O and decreases for group O-
BS. One interesting finding was the high correlation
between levels of CAVI and body mass index in group
O, which was not observed for groups O-BS or C. The
differences between groups, mainly regarding salivary
proteins involved in taste sensitivity and metabolism,
point to the potential of using saliva in the study of
obesity development.
Keywords Alpha-amylase . Bariatric surgery . Carbonic
anhydrase VI . Obesity . Salivary proteome
Introduction
Obesity is regarded as having achieved epidemic pro-
portions in both developed and developing countries,
having major negative economic and personal impacts.
Despite considerable investment in research, the preva-
lence of obesity has not decreased significantly,
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suggesting the lack of effectiveness of the methods
currently used in its treatment and prevention [11]. The
need for a better understanding of the pathophysiologi-
cal mechanisms involved in the development of obesity
is evident.
Saliva was first used as a non-invasive alternative to
blood, aiding in the diagnosis of different pathophysio-
logical conditions and providing an improved under-
standing of them. Besides comprising secretions from
three pairs of major salivary glands and numerous minor
glands, this fluid is also composed of substances derived
from the blood which enter it intracellularly or through
ultrafiltration at tight junctions between cells.
Concerning obesity, saliva composition has not been
extensively studied. Nevertheless, recent studies report-
ed the use of saliva for quantification of hormones as
well as for the search of biomarkers of inflammation and
insulin resistance [9] or of lipid metabolism [44].
Besides this potential of saliva as a source of bio-
markers, an additional aspect that makes saliva particu-
larly useful for the study of obesity is its role in oral food
perception and ingestion. Poor dietary habits are one of
the main factors suggested as contributing to the devel-
opment of obesity, with high-calorie and palatable foods
usually consumed rather than bitter-tasting and fibrous
vegetables [13]. Since dietary choices depend to a large
degree on oral perception, fluctuations in the factors that
influence taste and other oral sensations can play an
important role in weight gain. Changes in taste sensitiv-
ity have been referred to in studies of obesity, especially
regarding sweetness and bitterness. Although there is
some controversy as to whether these are perceived with
less or equal intensity by individuals with high body
mass index (BMI) [12], most studies report that obese
individuals present higher liking ratings for sweetness
[40] and more pronounced aversive reactions to bitter-
ness [17] than normal-weight subjects.
Saliva composition has an influence on sensitivity to
tastes and other oral sensations [38]. Salivary carbonic
anhydrase VI (CA VI) has been suggested as being
involved in bitter taste detection. Polymorphisms in
the gene coding for this salivary protein appear to con-
tribute towards explaining some of the variation in
sensitivity to the bitter compound 6-n-propylthiouracil
(PROP) [33]. Moreover, support for the role of saliva in
taste perception has been provided by a number of
studies reporting salivary proteins as being linked to
sensitivity to PROP bitterness [6, 27], to the bitter com-
pound caffeine [15], and even to the perception of fat
[32]. For example, cystatins and zinc-alpha-2 glycopro-
tein have been observed to be present in higher or lower
amounts, respectively, in saliva from children presenting
higher acceptance for bitter taste. The exact effect of
these proteins in taste perception is not known.Whereas
zinc-alpha-2 glycoprotein is a protein with different
functions, among which is initiation of lipid
mobilisation [18], cystatins are cysteine protease inhib-
itors. These last are involved in the control of proteolysis
within the oral cavity, and, for that reason, it was
hypothesised that they could affect the accessibility of
tastant molecules to taste receptors, influencing taste
sensitivity [15]. Another salivary protein potentially
involved in ingestion is alpha-amylase. Although a link
between this protein and taste perception has not been
reported, it is involved in carbohydrate digestion and
absorption, having also a role in the perception of
starchy foods [25]. The potential interest in examining
alpha-amylase in the study of obesity is increased by the
known relation between this protein’s concentration
levels and the activity of the sympathetic nervous sys-
tem [31], which is involved in energy balance and
implicated in the development and maintenance of obe-
sity [42]. Despite what has been stated above, a limited
number of studies on the biochemical characteristics of
saliva in obese individuals have been carried out. Fur-
thermore, most research has focused on parameters such
as flow rate, electrolytes, and total protein amounts,
mainly in the context of the development of dental caries
(e.g. [28]). The aims of this study were to identify
putative changes in salivary protein profiles in morbidly
obese women and to evaluate the effect of weight loss
on these profiles.
Methods and procedures
Study population and whole-saliva collection
The study population consisted of 18 women volunteer
patients aged 22 to 56 years from the Department of
Endocrinology, Diabetes and Metabolism of Santa
Maria Hospital (HSM) in Lisbon, Portugal. Two groups
of obese individuals were formed, one composed of
morbidly obese individuals (group O, N=11; mean
BMI 44.8 kg/m2) and the other comprising obese indi-
viduals who had previously been subjected to bariatric
surgery (gastric sleeve), having subsequently experi-
enced body weight loss in the range 30–50 kg (group
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O-BS, N=7; mean BMI 34.9 kg/m2). Healthy women
volunteers of normal weight in the same age range made
up a control group (group C, N=14; mean BMI 21.1 kg/
m2). The study was approved by the local ethics com-
mittee and all participating individuals gave their written
informed consent.
Unstimulated whole saliva was collected from
3.00 p.m. to 5.00 p.m. by direct draining into an ice-
cold collection tube. Subjects refrained from eating and
drinking for at least 1 h before collection. Samples were
divided into different aliquots and stored at −20 °C.
Preceding analysis, saliva samples were thawed on
ice and centrifuged for 30 min, 4 °C, 13,000g, for
removal of cells and mucinous material. Supernatant
total protein concentration was assayed using the Brad-
ford method (Bio-Rad Protein Assay).
Salivary protein profile
Sodium dodecyl sulfate-polyacrylamide gel electropho-
resis (SDS-PAGE) protein profiles were obtained for all
individuals in 12 % polyacrylamide gels (80×100×
0.75 mm) (Protean xi, Bio-Rad). The protein load per
sample was 7 μg and each individual sample was run in
triplicate. An electrophoretic run was performed at a
constant voltage of 150 V. Gels were fixed for 1 h in
40 % methanol/10 % acetic acid, followed by staining
for 2 h with Coomassie Brilliant Blue (CBB)G-250. Gel
images were acquired using a scanning Molecular Dy-
namics densitometer with internal calibration and
LabScan software (GE Healthcare), and images were
analysed using GelAnalyzer software (GelAnalyzer
2010a by Istvan Lazar, www.gelanalyzer.com).
Molecular masses were determined in accordance with
molecular mass standards run with protein samples.
Given the small size of samples taken from individ-
uals, and in order to reduce the influence of biological
variation, the saliva of five individuals from each exper-
imental group was pooled for 2D gel electrophoresis
analysis. Pools were made up in such a way that each
individual contributed the same amount of protein for
the required total. Each pool was run in duplicate. In
order to assess inter-individual variability within each
group and confirm the results of the comparison of
pools, individual gels from three different participants
from each experimental group were run. The protein
load was 160 μg both for pools and individual gels.
Saliva samples were desalted and concentrated using
3-kDa cut-off ultra-filtration microfuge tubes (Nanosep
3K omega, PALL Corporation) and then mixed with
rehydration buffer {7 M urea, 2 M thiourea, 4 % (w/v)
CHAPS [3-(3-cholamidopropyl dimethylammonio)-1
propanesulfonate], 2 % (v/v) IPG buffer, 60 mM dithio-
threitol (DTT), and bromophenol blue 0.002% (w/v)} to
a final volume of 250 μL and loaded onto 13-cm pH 3–
10 NL IPG strips (GE Healthcare) by passive in-gel
rehydration overnight in a Multiphor Reswelling Tray
(GE Healthcare). Strips were focused for 30 kVh at
18 °C, using a Multiphor II isoelectric focusing system
(GE Healthcare). Following focusing, proteins in the
IPG strips were reduced by soaking in 1 % (w/v) DTT;
50mMTris–HCl, pH 8.8; 6M urea; 30% (v/v) glycerol;
and 2 % (w/v) SDS, and then alkylated with 65 mM
iodoacetamide; 50 mM Tris–HCl, pH 8.8; 6 M urea;
30 % (v/v) glycerol; and 2 % (w/v) SDS. The equilibrat-
ed strips were then horizontally applied on the top of a
12 % SDS-PAGE gel (1×160×160 mm), and proteins
were separated vertically at 18 °C, using a Protean II xi
cell (Bio-R'ad) at a constant voltage of 150 V until the
end of the run. Gels were stained with 0.1 % CBB-R250
(in 40 % methanol, 10 % acetic acid) and de-stained
with 10 % acetic acid.
Digital images of the 2-DE gels were acquired
using the same procedure as that described for SDS-
PAGE image acquisition. Gel analysis was per-
formed using Image Master Platinum v.7 software
(GE Healthcare), with automatic spot detection,
followed by manual editing for spot splitting and
noise removal. A total of 15 gels were analysed (2
pool and 3 individual gels from each group), and the
volume of each spot was normalised using relative
spot volumes (% vol). In order to calculate fold
change, the spot volume of obese subjects was di-
vided by the spot volume of healthy subjects. Only
protein spots that changed ≥1.5-fold and consistent-
ly changed in the same manner for individual gels
were considered to be differently expressed. These
spots were then removed and analysed using matrix-
assisted laser desorption/ionization time-of-flight
(MALDI-TOF)/TOF mass spectrometry (MS).
Protein identification
Tryptic digestion
Spots of interest were manually excised from gels,
washed three times in 25 mM ammonium bicarbonate/
50 % ACN, washed once in ACN, and dried in a
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SpeedVac (Thermo Savant). Twenty-five microlitres of
10 μg/mL sequence-grade modified porcine trypsin
(Promega) in 25mMammonium bicarbonate was added
to the dried gel pieces, and the samples were incubated
overnight at 37 °C. Extraction of tryptic peptides was
performed by means of the addition of 10 % formic acid
(FA)/50 % ACN being dried in a SpeedVac (Thermo
Savant).
Mass spectrometry
Tryptic peptides were re-suspended in 10 μL of a 50 %
acetonitrile/0.1 % formic acid solution. The samples
were mixed (1:1) with a matrix consisting of a saturated
solution of α-cyano-4-hydroxycinnamic acid prepared
in 50 % acetonitrile/0.1 % formic acid. Aliquots of
samples (0.5 μL) were spotted onto the MALDI sample
target plate.
Peptide mass spectra were obtained on a MALDI-
TOF/TOFmass spectrometer (4800 Proteomics Analyz-
er, Applied Biosystems, Europe) in the positive ion
reflector mode. Spectra were obtained in the mass range
from 800 to 4500 Da with ca. 1500 laser shots. For each
sample spot, a data-dependent acquisition method was
created in order to select the six most intense peaks,
excluding those of the matrix, trypsin autolysis, and
acrylamide peaks, for subsequent MS/MS data acquisi-
tion. Mass spectra were internally calibrated with
autodigest peaks of trypsin (MH+: 842.5, 2211.42 Da)
allowing for a mass accuracy of approximately 25 ppm.
Database search
Spectra were processed and analysed using a Global
Protein ServerWorkstation (Applied Biosystems), using
internal MASCOT software (v2.1.0, Matrix Science,
London, UK) for searching the peptide mass finger-
prints and MS/MS data. The Swiss-Prot non-redundant
protein sequence database (March 2013) was used for
all searches under Homo sapiens. Database search pa-
rameters were as follows: carbamidomethylation and
propionamide of cysteine as a variable modification as
well as oxidation of methionine, and the allowance for
up to two missed tryptic cleavages. Peptide mass toler-
ance was 25 ppm and fragment ion mass tolerance was
0.3 Da. Positive identifications were accepted to a con-
fidence level of 95 %. Criteria for positive identification
were a significant MASCOT probability score (score
>50; p<0.05).
Western blotting
Western blotting was used to verify the hypothesis evi-
denced by SDS-PAGE and 2D gels for changes in the
abundance of CAVI and alpha-amylase. Protein loadwas
adjusted to 3 μg per lane, and electrophoresis was carried
out in 12 % polyacrylamide gels, using the protocol
described above. Proteins were subsequently transferred
to PVDF membranes at 350 mA constant current for 1 h.
Membranes were stained with Ponceau S (0.2 % (w/v);
3 % (v/v) acetic acid) for the control of suitable protein
load and transfer. After a blocking step in 5 % (w/v)
powdered skimmed milk in TBS–Tween for 2 h, mem-
branes were incubated with primary antibodies (Santa
Cruz sc-46657 and sc-99173; 1:200 dilutions) overnight
(4 °C). Salivary alpha-amylase and CA VI bands were
detected using an alkaline phosphatase-linked secondary
antibody against mouse IgG and rabbit IgG (GE
Healthcare, 1:10,000 dilution), respectively, and a
chemifluorescent substrate (ECF Plus Western Blotting
Detection Reagents, GE Healthcare). Membranes were
revealed in a transilluminator (Gel-doc system, Bio-Rad),
and a semi-quantitative analysis of band expression was
carried out using Quantity One software (Bio-Rad).
Salivary alpha-amylase enzymatic activity
Alpha-amylase enzymatic activity was determined using
a colorimetric commercial kit (Liquid amylase, Sentinel
Diagnostics), based on the catalysis of the hydrolysis of
p-nitrophenyl-maltoheptaoside-4,6-ethylidene blocked
by alpha-amylase with the formation of products which
were subsequently hydrolysed into p-nitrophenol (PNP)
and glucose. The increase in absorbance due to PNP
formation was proportional to the activity of alpha-
amylase in the sample examined. The protocol was
performed in 96-well plates, in accordance with the
manufacturer’s instructions. For the assay, dilutions of
100, 200, 300, 400, and 500× from saliva samples were
used. Absorbance at 405 nm was read each minute for
15 min. Linearity was observed in the interval between 5
and 10 min. Enzyme activity was expressed as the num-
ber of moles of PNP formed per minute, per milligram of
protein (U/mg) or per liter of saliva (U/L).
Statistical analysis
All data were analysed using descriptive statistics, and
normality and homoscedasticity were evaluated using
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the Kolmogorov–Smirnov and Levene tests, respective-
ly. To assess differences between treatments for param-
eters such as SDS-PAGE profiles, Western blot protein
band expression, and alpha-amylase enzymatic activity,
one-way ANOVA was performed. Means were com-
pared using Duncan’s test. Salivary parameters were
related to BMIs by means of the Pearson correlation.
Statistical significance was considered for p<0.05. All
statistical analysis procedures were performed using the
SPSS 21.0 software package (SPSS Inc., Chicago,
USA).
Results
Characterisation of participants
The anthropometric characteristics of the women partic-
ipating in the study are presented in Table 1. Differences
in BMI among groups are clear. Although women from
group O presented some weight loss since the start of
their visits to the Department of Endocrinology, Diabe-
tes and Metabolism of HSM in Lisbon, they were con-
siderably lower than the ones derived from bariatric
surgery experienced by women from group O-BS.
Total protein concentration
Total protein concentration in saliva was found to differ
between groups. Obese individuals who had not been
subjected to bariatric surgery (O) presented significantly
higher values than those belonging to the two other
groups, and the mean value for these individuals was
almost twice as high as that of members of the control
group (C) (850.3±99.0 vs. 483.1±44.7 μg/mL,
respectively; p=0.004). The salivary protein concentra-
tion of obese individuals who had been subjected to
bariatric surgery (O-BS) did not differ from that of the
group of non-obese subjects (520.3±54.2 μg/mL in O-
BS saliva; p=0.372).
Salivary protein profile
Salivary protein profiles observed after SDS-PAGE sep-
aration presented differences with regard to three protein
bands. One protein band, with 92 kDa, was observed in
higher abundance in group O (11.36±1.79 % vol) com-
paratively to group O-BS (8.42±3.2 % vol), although
these groups did not significantly differ from normal-
weight individuals. Protein bands with 57 and 42 kDa
presented lower abundance in O-BS individuals as com-
pared with the two other groups. [For the band with
57 kDa, 9.1±2.9 (O-BS) vs. 11.5±2.6 (O) and 10.0±
3.7 % vol (C); p values, 0.048 for O-BS vs. O and 0.009
for O-BS vs. C. For the band with 42 kDa, 6.7±2.9 (O-
BS) vs. 12.8±3.0 (O) and 9.5±2.7 % vol (C); p values,
0.024 for O-BS vs. O and 0.047 for O-BS vs. C.] One
protein band with approximately 25 kDa presented
higher abundance for group O only (11.6±2.2 for O
vs. 9.2±1.8 and 10.0±2.2 % vol for groups O-BS and
C, respectively; p=0.005 O-BS vs. O and p=0.049 O
vs. C). In the region of 16 kDa, a tendency for higher
protein expression in group O-BS (9.2±1.8 % vol) as
compared with group C (7.6±2.0 % vol) was also ob-
served, although these last differences were not statisti-
cally significant (p=0.07) and some intra-group vari-
ability was observed. This may be associated with the
location of this band: in the vicinity of the lower end of
the gel.
Table 1 Anthropometric characteristics of subjects
C (N=14) O (N=11) O-BS (N=7) p value
Mean SD Mean SD Mean SD
Age 36.1 3.1 39.7 3.7 44.1 4.2
Weight (kg) 57.5 2.5 114.9 5.6 94.2 7.5 §0.0000 #0.0020
Height (m) 1.66 0.02 1.60 0.02 1.64 0.03
BMI (kg/m2) 21.1 0.5 44.8 1.8 34.9 2.1 §0.0000 #0.0003
Weight loss (kg) 0.0 0.0 6.1 2.5 42.0 3.8 §0.0000 #0.0000
SD standard deviation
p value <0.05, statistically different group from the control group: § O and #O-BS as compared with group C, respectively
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A total of 91 and 101 protein spots were observed for
2-DE salivary profiles of pooled saliva samples from
group C and the two groups of obese individuals, re-
spectively. Of these, the % vol of 23 spots differed by
more than twofold: for 19 spots, differences were
observed between group C and the two groups of
obese individuals (O and O-BS); for 2 spots, diffe-
rences were observed only between the control group
and group O; and for the other 2 spots, differences
were observed only between the control group and
group O-BS (Fig. 1).
The protein spots identified by means of mass spec-
trometry are listed in Table 2. Some differences in protein
spot levels, in comparison with the control group, were
observed to be specific for each obese group: (i) two
different spots, identified as the protein zinc-α-2 glyco-
protein (UniProt: P25311), presented higher levels for
group O only and (ii) one spot, identified as transmem-
brane protease serine 13 (UniProt: Q9BYE2), presented
increased levels and another one, identified as salivary
amylase (UniProt: P04745), presented decreased levels in
O-BS individuals only. With the exception of one spot
(spot 137 in Fig. 1), all spots whose levels were decreased
in obese subjects were identified as salivary amylase
(UniProt: P04745). Meanwhile, five spots which were
increased for both obese groups were also identified as
salivary amylase (UniProt: P04745), but in this case, all
with apparent molecular masses which were smaller than
the theoretical molecular mass of this protein (three ob-
served with apparent molecular masses of 27 kDa vs.
theoretical molecular mass of 58 kDa). The non-
identified protein spot 137 was located at the acidic end
of the gel, presenting an apparent molecular mass of
25 kDa, and was stained violet with Coomassie R-250
after being de-stained with acetic acid only (not shown).
This suggests the possibility of this being an acidic
proline-rich protein [2]. Finally, one spot (108), observed
to be increased in both groups of obese subjects, was
identified as cystatin S (UniProt: P01036). The remaining
unidentified spots may have either contained insufficient
amounts of protein or belonged to proteins with fragmen-
tation patterns which were unfavourable for reliable MS/
MS sequencing.
Alpha-amylase abundance and enzymatic activity
Alpha-amylase was identified by means of Western
blotting for two bands of 63 and 57 kDa (Fig. 2).
Differences were observed for the abundance of this
protein, and the individuals from group O-BS presented
lower levels.
The enzymatic activity of salivary alpha-amylase
expressed per volume of saliva (U/L) was significantly
increased in group O, presenting twice the level of activ-
ity of the control group (245.7×103±35.8×103 vs.
111.2×103±43.8×103 U/L, respectively) (Fig. 3). It is
interesting to note that the specific enzymatic activity
(U/mg protein) did not present a statistically significant
difference, comparatively to the control group (366.9±
82.0 and 198.4±68.6 U/mg, respectively). This is in
accordance with protein expression results, obtained after
Western blot and SDS-PAGE analysis, where no signif-
icant differences were observed between groups O and C.
Group O-BS did not differ from normal-weight individ-
uals (130.0×103±36.7×103 U/L and 242.0±83.0 U/mg).
Changes in CAVI abundance
One band, with an apparent molecular mass of 42 kDa,
was identified as CAVI by means of Western blotting.
Its expression in O-BS individuals was about half that
observed for the control group (Fig. 4). This was in
accordance with results obtained on the basis of SDS-
PAGE profile analysis, whereas the band with an
Fig. 1 Venn diagrams of the
protein datasets differently
expressed from the control group.
Two pools for each group, each
consisting in saliva from five
different individuals, were used to
produce the diagram
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apparent molecular mass of 42 kDa presented a de-
creased expression in this group, as stated before.
The abundance of CAVI was strongly correlated with
BMI in obese individuals (r=0.701; p=0.001). This was
particularly evident in the case of group O individuals (r=
0.67; p=0.018), with no correlation observed when con-
sidering only individuals from group O-BS. This suggests
that, without intervention aimed at producing weight loss,
there was a tendency for individuals with a higher BMI to
present higher CAVI levels. On the other hand, for indi-
viduals with normal weight (the control group), the ex-
pression of this salivary protein did not correlatewithBMI.
Discussion
During the last 20 years, the salivary proteome has been
studied with regard to different pathologies, due to the
potential of saliva as a non-invasive source of bio-
markers of diseases and/or physiological conditions
[7]. Although the knowledge of variations in salivary
protein composition may have the potential for elucidat-
ing the physiological mechanisms involved in the de-
velopment of obesity, or even for making inferences
about individuals’ susceptibility to this condition, few
studies have been carried out on this topic. We recently
Table 2 MS identification of differentially expressed salivary proteins
Spot Protein (UniProt
entry reference)
Estimated/
theoretical
MW (kDa)
Estimated/
theoretical pI
Id score/
PM
Fold of variationa
(C vs. O)
Fold of variationa
(C vs. O-BS)
Protein function/invol
vement in oral perception
2 Salivary amylase
(P04745)
67/58 6.0/6.5 112/5 2.5 2.1 - Endohydrolysis of (1->4)-
alpha-D-glucosidic linkages
in polysaccharides containing
three or more (1->4)-alpha-
linked D-glucose units
- Possible involvement in oral
starch perception [25]
3 57/58 6.0/6.5 275/9 3.0 3.9
15 67/58 6.7/6.5 113/4 5.7 18.8
45 57/58 6.7/6.5 149/8 3.4 4.4
51 67/58 5.5/6.5 108/6 –b 2.6
52 57/58 5.5/6.5 80/3 2.0 4.0
106 52/58 6.7/6.5 91/5 n.m./obs n.m./obs
116 27/58 6.5/6.5 103/4 n.m./obs n.m./obs
117 27/58 6.7/6.5 57/3 n.m./obs n.m./obs
118 27/58 7.7/6.5 80/3 n.m./obs n.m./obs
127 52/58 6.0/6.5 88/3 n.m./ct n.m./ct
90 Zinc-α-2-
glycoprotein
(P25311)
45/34 5.2/5.7 77/3 –b n.m./obs - Stimulates lipid degradation in
adipocytes and causes
extensive fat losses associated
with some advanced cancers.
May bind polyunsaturated
fatty acids
- Possible association to bitter
taste sensitivity [29]
92 45/34 5.3/5.7 67/2 n.m./obs n.m./obs
104 Transmembrane
protease
serine 13
(Q9BYE2)
18/63 4.9/9.0 58/2 n.m./obs - Serine protease activity, known
to function in development,
homeostasis, infection, and
tumorigenesis
108 Cystatin S
(P01036)
15/16 5.0/5.0 254/6 n.m./obs n.m./obs - Strongly inhibits cysteine
proteases such as papain and
ficin, among others
- Potentially related to bitter
taste sensitivity [14]
MWmolecular weight, C control group, O obese group,O-BS obese subjected to bariatric surgery group, PM number of peptides matched,
n.m. fold of variation not measureable because protein spot was only observed in the gels from one of the obese groups (obs) or only in gels
from the control group (ct)
a Values represent the ratio of spot percentage volumes between the control and each group of obese individuals
b No differences relative to group C
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observed that young rats, prone to obesity, presented
higher salivary alpha-amylase levels than animals resis-
tant to the development of obesity, suggesting the pos-
sible use of saliva in signalling individuals susceptible to
weight gain [37].
Because saliva composition is influenced by gender
[21], only women were selected as subjects for the
present study. A higher total protein concentration was
observed in the saliva of obese individuals who had not
been subjected to bariatric surgery, in line with reports
on obese children and adolescents [34], and men [36].
Interestingly, women who had been subjected to
bariatric surgery did not present increased levels of total
salivary proteins, as compared to the control group,
suggesting that weight loss may reverse such salivary
change.
One major finding of the present study is the obser-
vation of differences in obese salivary protein profiles,
as compared with those of individuals with normal
weight, and some differences resulting from the exis-
tence or absence of weight loss induced by bariatric
surgery.
Salivary alpha-amylase abundance was significantly
reduced in the group of individuals who had been
Fig. 2 Representative Western
blot analysis of alpha-amylase in
mixed saliva samples from the
control group (C), the group of
morbidly obese women (O), and
the group of morbidly obese
women who had been subjected
to bariatric surgery (O-BS) (a).
Optical density was obtained
using densitometric analysis.
These values comprehend
background correction, which
was applied for each band by
normalising to an adjacent region
of the membrane (b). Data are
presented as mean±SEM
(*p<0.05, statistically significant
differences)
Fig. 3 Salivary alpha-amylase
activities (U/L and U/mg) of
mixed saliva samples from the
control group (C), the group of
morbidly obese women who had
been subjected to bariatric surgery
(O-BS), and the group of
morbidly obese women (O). Data
are presented as mean±SEM
(*p<0.05, statistically significant
differences)
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subjected to bariatric surgery, observed in both SDS-
PAGE profiles and Western blotting. Moreover, six of
the spots from 2-DE profiles, identified as salivary am-
ylase, also presented lower abundance for this group.
Furthermore, the enzymatic activity was also signifi-
cantly decreased as compared with group O. Studies
carried out on diabetic individuals have suggested that
alpha-amylase levels may be associated with insulin
secretion [22], and there are reports of higher levels of
amylase in individuals with type 2 diabetes (associated
with hyperinsulinaemia) (e.g. [24]) and lower levels in
type 1 diabetics (e.g. [23]). However, no information
about insulin levels was obtained with regard to the
subjects in the present study, almost all of those in group
O reporting as being diabetics. Moreover, it is known
tha t obes i t y i s gene r a l l y a s soc i a t ed wi th
hyperinsulinaemia, in the presence or absence of type
2 diabetes. In turn, sleeve gastrectomy has been reported
to reverse metabolic changes, including lowering insulin
levels in individuals who are fasting [8].
Salivary alpha-amylase abundance has also been
suggested as a marker of stress and sympathetic nervous
system activity [31]. Some studies suggest that obesity
is associated with increases [20], whereas weight loss is
related to decreases in sympathetic nervous system ac-
tivity [42]. Thus, the high levels of this protein in group
O and the low levels of the protein in group O-BS may
partly reflect the activity of this branch of the autonomic
nervous system. An interesting point to note is the
different changes in the several spots identified as sali-
vary alpha-amylase. Increases in salivary amylase spots
with apparent molecular masses smaller than the native
salivary amylase molecular mass (57 kDa) were ob-
served in the two groups of obese individuals. Low
molecular mass salivary amylase isoforms have previ-
ously been reported, although their biological role is yet
to be investigated [19]. Consequently, a better knowl-
edge of each isoform and its involvement in the devel-
opment of obesity and/or weight loss may be useful.
Additionally, changes in salivary amylase levels in
obese individuals may be of relevance due to the involve-
ment of this protein in food ingestion and digestion.
Despite a direct relationship between this salivary protein
and taste not having been reported, a recent study de-
scribed differences between individuals with variable
levels of sensitivity to oleic acid, with one protein spot
being identified as salivary amylase [30]. This protein
produces changes in the viscosity perception of starchy
foods [25] resulting in increases in the levels of the sweet
molecules maltose and glucose in the mouth [39]. We
therefore put forward the hypothesis that during the con-
sumption of starch-containing foods, lower levels and
lower enzymatic activities of this salivary protein in
individuals who have been subjected to bariatric surgery
may result in a lower concentration of sweet compounds
in the mouth as compared with group O individuals. This
in turn may result in different levels of sweetness percep-
tion, since changes in taste sensitivity due to the contin-
uous stimulation of taste receptors by salivary constitu-
ents have already been suggested [26]. Although this is
only a hypothesis, since no sensory evaluation was
Fig. 4 Representative Western blot analysis of carbonic
anhydrase VI in mixed saliva samples from the control group
(C), the group of morbidly obese women who had been subjected
to bariatric surgery (O-BS), and the group of morbidly obese
women (O) (a). Signal volumes adjusted (optical density) were
obtained using densitometric analysis. These values comprehend
background correction, which was applied for each band by nor-
malising to an adjacent region of the membrane (b). Data are
presented as mean±SEM (*p<0.05, statistically significant
differences)
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performed with regard to the subjects in this study, the
high enzymatic activity observed in groupOmay provide
support for the studies reporting low levels of sweet taste
sensitivity combined with strong preferences for sweet
foods in obese individuals [1]. Furthermore, the small
quantities of this enzyme present following bariatric sur-
gery may be related to potential recovery of sweet taste
sensitivity which had already been reported for these
individuals [4].
Concerning the higher abundance of the spot identi-
fied as transmembrane protease serine in group O-BS as
compared with the other two groups, no obvious con-
clusions can be drawn. This protease has been identified
as a constituent of human saliva which has a role to play
in histatin proteolysis [43]. Although it is associated
with the human phenotype linked to starvation [3], its
role in the composition of saliva is not well understood.
Zinc-α-2 glycoprotein presented higher values only in
obese individuals who had not been subjected to bariat-
ric surgery. In another study, higher serum levels of this
protein were found for obese individuals than for those
with normal weight [45]. Consequently, the increased
expression of this protein in the saliva of obese individ-
uals, observed in our study, may reflect higher levels of
the protein in the blood. Since changes in levels of this
protein have been recently reported according to bitter
taste acceptance in children [29], it is possible that
differences between obese and normal-weight individ-
uals are related to differences in oral food perception.
Although identification by means of MS failed for one
protein spot, observed as presenting decreased levels in
the two groups of obese individuals, this spot was
stained pink, suggesting that it may be a proline-rich
protein (PRP). Despite the different functions attributed
to these proteins, including oral protection, a significant
role in the oral perception of astringency has been
suggested for them (e.g. [10]) and one study has report-
ed a positive relationship between levels of these pro-
teins and bitter taste sensitivity [6]. Other salivary pro-
teins potentially associated with taste sensitivity were
observed to be differently expressed in obese individ-
uals who had been subjected to bariatric surgery: one
cystatin S spot was present at higher levels, whereas CA
VI protein abundance was decreased. Meanwhile,
cystatin S levels were observed to be increased in indi-
viduals with low bitter taste sensitivity, in both men [15]
and women (Rodrigues et al., not published). Moreover,
levels of salivary CAVI have been suggested as being
positively associated with bitter taste perception [6],
although there is some controversy regarding this
issue [16, 35]. There are conflicting results regard-
ing the effect of bariatric surgery on bitter taste
perception (some authors report changes [41],
while others do not [5]). However, if it is assumed
that the reports of studies relating PRPs, cystatin
S, and CA VI abundance with bitter taste sensitiv-
ity are correct, this surgical procedure may be
suggested as being related to a decrease in bitter
taste sensitivity. Similarly, the tendency for the
higher protein abundance of CA VI in individuals
with a higher BMI, observed only for group O-BS,
may also be related to higher levels of bitter taste
sensitivity. This matter requires further investiga-
tion since, if it is established that this is correct,
this may be of significance in terms of the accep-
tance of healthy foods (e.g. vegetables), which are
usually associated with increased bitter taste.
In conclusion, the results of this study clearly showed
a salivary proteome for obese individuals which differed
from that of normal-weight subjects. Moreover, some
differences were not observed in the case of those who
had been subjected to bariatric surgery. Some proteins
presenting different levels may be related to the meta-
bolic changes associated with obesity, whereas others
are salivary proteins which have been referred to as
being involved in taste perception. The findings of this
study point to the possible use of saliva in the study of
obesity and suggest a possible relationship between the
salivary proteome and taste sensitivity in obese indivi-
duals, which can eventually result in different food
intakes. Further research should be carried out in order
to clarify the relation between the differences observed
in this study and possible differences in oral food per-
ception in obese individuals.
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